ArticleNeuro-oncology2025

Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.

Katharina J Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.